Nizankowska M H, Lukasik-Czerek A, Popiela G, Oficjalska-Młyńczak J, Zajac-Pytrus H, Turno-Krecicka A
Z Katedry i Kliniki Okulistyki AM we Wrocławiu.
Klin Oczna. 1995 Sep-Oct;97(9-10):282-5.
To evaluate the incidence of ME, its characteristics, and results of its treatment with laser coagulation.
In the analysed group there were 478 subjects with diabetes mellitus--84 with a diagnosis before 30 years of age and 394 with a diagnosis at 30 years of age or older. In the older-onset group there were 64% taking insulin. Mean age of the group was 61 years and mean period of duration of diabetes was 16 years. The methods of ophthalmological examination included stereoophthalmoscopy and fluorescein angiography. In 845 examined eyes there were 832 eyes with mild-to-severe nonproliferative and moderate-to-high risk proliferative diabetic retinopathy.
The incidence of macular edema was 81.6%. These data suggest high incidence of macular edema and its high severity (V < 0.2 = 47%) over the 15-years period of duration of diabetes. Treatment included focal coagulation, macular grid and PRK performed with argon laser.
The results of laser coagulation demonstrated that focal photocoagulation was effective in reducing the risk of moderate visual loss. When macular edema was more severe, macular grid before scatter (panretinal) photocoagulation for proliferative retinopathy decreased the frequency of persistent ME.
评估黄斑水肿(ME)的发生率、特征及其激光凝固治疗的效果。
分析组中有478例糖尿病患者,其中84例在30岁之前确诊,394例在30岁及以上确诊。在老年发病组中,64%的患者使用胰岛素。该组的平均年龄为61岁,糖尿病平均病程为16年。眼科检查方法包括立体眼底镜检查和荧光素血管造影。在845只受检眼中,有832只眼患有轻度至重度非增殖性和中度至高风险增殖性糖尿病视网膜病变。
黄斑水肿的发生率为81.6%。这些数据表明,在糖尿病病程15年期间,黄斑水肿的发生率高且严重程度高(视力小于0.2 = 47%)。治疗包括使用氩激光进行局部凝固、黄斑格栅光凝和准分子激光角膜切削术(PRK)。
激光凝固治疗的结果表明,局部光凝有效地降低了中度视力丧失的风险。当黄斑水肿更严重时,在增殖性视网膜病变的散射(全视网膜)光凝之前进行黄斑格栅光凝可降低持续性黄斑水肿的发生率。